ALMo: Interactive Aim-Limit-Defined, Multi-Objective System for Personalized High-Dose-Rate Brachytherapy Treatment Planning and Visualization for Cervical Cancer

๐Ÿ“… 2026-02-14
๐Ÿ“ˆ Citations: 0
โœจ Influential: 0
๐Ÿ“„ PDF
๐Ÿค– AI Summary
This study addresses the complex clinical trade-offs in high-dose-rate brachytherapy for cervical cancer, where treatment planning must balance tumor coverage, organ-at-risk sparing, and hot spot controlโ€”a process often hindered by subjectivity and inefficiency. The authors propose a novel multi-objective optimization framework grounded in an โ€œAim-Limitโ€ paradigm to build an interactive decision support system. By allowing clinicians to intuitively specify aim values and constraint limits, the system automatically infers clinical intent and integrates Pareto front visualization with interactive dosimetric analysis to enable flexible toxicity risk management while minimizing manual intervention. In a retrospective evaluation of 25 cases, 65% of the automatically generated plans demonstrated superior dosimetric quality compared to manual plans, and the average planning time was reduced from 30โ€“60 minutes to approximately 17 minutes.

Technology Category

Application Category

๐Ÿ“ Abstract
In complex clinical decision-making, clinicians must often track a variety of competing metrics defined by aim (ideal) and limit (strict) thresholds. Sifting through these high-dimensional tradeoffs to infer the optimal patient-specific strategy is cognitively demanding and historically prone to variability. In this paper, we address this challenge within the context of High-Dose-Rate (HDR) brachytherapy for cervical cancer, where planning requires strictly managing radiation hot spots while balancing tumor coverage against organ sparing. We present ALMo (Aim-Limit-defined Multi-Objective system), an interactive decision support system designed to infer and operationalize clinician intent. ALMo employs a novel optimization framework that minimizes manual input through automated parameter setup and enables flexible control over toxicity risks. Crucially, the system allows clinicians to navigate the Pareto surface of dosimetric tradeoffs by directly manipulating intuitive aim and limit values. In a retrospective evaluation of 25 clinical cases, ALMo generated treatment plans that consistently met or exceeded manual planning quality, with 65% of cases demonstrating dosimetric improvements. Furthermore, the system significantly enhanced efficiency, reducing average planning time to approximately 17 minutes, compared to the conventional 30-60 minutes. While validated in brachytherapy, ALMo demonstrates a generalized framework for streamlining interaction in multi-criteria clinical decision-making.
Problem

Research questions and friction points this paper is trying to address.

HDR brachytherapy
multi-objective optimization
clinical decision-making
dose planning
cervical cancer
Innovation

Methods, ideas, or system contributions that make the work stand out.

interactive multi-objective optimization
aim-limit interface
HDR brachytherapy
Pareto navigation
treatment planning automation
๐Ÿ”Ž Similar Papers
No similar papers found.